<div
  id="info-inyectables-combinados"
  class="info-content hidden bg-white rounded-t-3xl"
>
  <div
    class="md:hidden bg-white rounded-lg overflow-hidden mb-6 "
  >
    <div
      class="bg-purple-abbott text-white p-4 text-center font-bold uppercase tracking-wide"
    >
      Anticonceptivos Inyectables Combinados
    </div>

    <div class="p-4 border-b border-gray-100">
      <span class="block text-black font-bold uppercase text-xs mb-1"
        >Cómo actúan</span
      >
      <p>Inhiben la ovulación</p>
    </div>

    <div class="p-4 border-b border-gray-100">
      <span class="block text-black font-bold uppercase text-xs mb-2"
        >Efectividad (Índice de Pearl)</span
      >
      <div class="flex gap-2">
        <div class="flex-1 p-3 rounded text-center">
          <span class="block text-2xl font-extrabold text-black">0,05</span>
          <span class="text-xs text-gray-600">Uso Correcto*</span>
        </div>
        <div class="flex-1 p-3 rounded text-center">
          <span class="block text-2xl font-extrabold text-black">3</span>
          <span class="text-xs text-gray-600">Uso Típico*</span>
        </div>
      </div>
    </div>

    <div class="p-4 border-b border-gray-100">
      <span class="block text-black font-bold uppercase text-xs mb-1"
        >Cuándo Iniciar</span
      >
      <p>
        En cualquier momento del mes.<br /><span class="text-xs text-gray-500"
          >>7 días desde el inicio de la menstruación, necesita método de respaldo por 7 días.</span>
      </p>
    </div>

    <div class="p-4">
      <span class="block text-black font-bold uppercase text-xs mb-1"
        >Modo de Uso</span
      >
      <p class="mb-2">Una inyección cada 4 semanas (7 días antes o después de la fecha programada).</p>
    </div>
  </div>

  <div class="overflow-x-auto px-2 md:px-0 rounded-t-3xl border border-purple-abbott">
    <table
      class="w-full border-collapse bg-white shadow-lg md:rounded-none rounded-lg overflow-hidden"
    >
      <thead class="hidden md:table-header-group text-white">
        <tr>
          <th
            colspan="7"
            class="bg-purple-abbott p-4 text-xl uppercase border-b-2 border-white"
          >
            Anticonceptivos Inyectables Combinados (AIC)
          </th>
        </tr>
        <tr class="bg-purple-abbott/70 text-xs uppercase">
          <th rowspan="2" class="border border-white p-2 border-b-purple-abbott border-l-purple-abbott">Cómo actúan</th>
          <th colspan="2" class="border border-white p-2"
            >Efectividad<sup>1</sup></th
          >
          <th rowspan="2" class="border border-white p-2 border-b-purple-abbott">Cuándo iniciar</th>
          <th rowspan="2" class="border border-white p-2 border-b-purple-abbott w-1/6">Modo / Frecuencia</th>
          <th rowspan="2" class="border border-white p-2 border-b-purple-abbott w-1/6">Opciones</th>
          <th rowspan="2" class="border border-white p-2 border-b-purple-abbott w-1/4"
            >Beneficios Adicionales</th
          >
        </tr>
        <tr class="bg-purple-abbott/70 text-xs uppercase">
          <th class="border border-white p-2 border-b-purple-abbott">Uso Correcto*</th>
          <th class="border border-white p-2 border-b-purple-abbott">Uso Típico*</th>
        </tr>
      </thead>

      <tbody class="block md:table-row-group">
        <tr
          class="flex flex-col md:table-row mb-4 md:mb-0 bg-white md:bg-transparent shadow md:shadow-none border border-purple-abbott md:border-none rounded-lg md:rounded-none overflow-hidden"
        >
          <td
            rowspan="4"
            class="hidden md:table-cell bg-purple-abbott/70 text-white font-bold text-center border border-purple-abbott p-3 text-lg align-middle"
          >
            Inhiben la ovulación
          </td>
          <td
            rowspan="4"
            class="hidden md:table-cell text-center border border-purple-abbott p-3 font-extrabold text-xl align-middle"
            >0,05</td
          >
          <td
            rowspan="4"
            class="hidden md:table-cell text-center border border-purple-abbott p-3 font-extrabold text-xl align-middle"
            >3</td
          >
          <td
            rowspan="4"
            class="hidden md:table-cell border border-purple-abbott p-4 align-middle"
          >
            <strong>En cualquier momento del mes:</strong><br /><br />
            <span class="text-xs"
              >>7 días desde el inicio de la menstruación, necesita método de respaldo por 7 días.</span
            >
          </td>
          <td
            rowspan="4"
            class="hidden md:table-cell border border-purple-abbott p-4 align-middle"
          >
            <strong>Una inyección cada 4 semanas</strong><br />
            <span class="text-xs block"
              >(7 días antes o después de la fecha programada)</span
            >
          </td>

          <td
            class="block md:table-cell p-4 md:text-black border border-purple-abbott text-center font-bold md:align-middle"
          >
            <span class="text-lg md:text-base">Nofertyl</span>
            <span
              class="block text-xs font-normal text-purple-abbott/80 md:text-gray-500 mt-1"
              >(EN-NET 50 mg / E2V 5 mg)</span
            >
          </td>
          <td
            class="block md:table-cell p-4 border border-purple-abbott  align-middle"
          >
            <span
              class="md:hidden text-black font-bold text-xs uppercase mb-2 block"
              >Beneficios:</span
            >
            <ul class="list-disc marker:text-[10px] text-xs md:text-sm">
              <li>Muy buena tolerabilidad y mejoría de la dismenorrea.<sup>2</sup></li>
              <li>Excelente adherencia en adolescentes y jóvenes.<sup>2</sup></li>
            </ul>
          </td>
        </tr>

        <tr
          class="flex flex-col md:table-row mb-4 md:mb-0 bg-white md:bg-transparent shadow md:shadow-none border border-purple-abbott md:border-none rounded-lg md:rounded-none overflow-hidden"
        >
          <td
            class="block md:table-cell p-4 md: text-black border border-purple-abbott text-center font-bold md:align-middle"
          >
            <span class="text-lg md:text-base">Femelin</span>
            <span
              class="block text-xs font-normal text-purple-abbott/80 md:text-gray-500 mt-1"
              >(MPA 25 mg / E2 cipionato 5 mg)</span
            >
          </td>
          <td
            class="block md:table-cell p-4 border border-purple-abbott  align-middle"
          >
            <span
              class="md:hidden text-black font-bold text-xs uppercase mb-2 block"
              >Beneficios:</span
            >
            <ul class="list-disc marker:text-[10px] text-xs md:text-sm">
              <li>Menos días de sangrado en cada ciclo.<sup>3</sup></li>
              <li>Mínimo impacto metabólico.<sup>2</sup></li>
              <li>Aplicación intramuscular o subcutánea.<sup>4</sup></li>
            </ul>
          </td>
        </tr>

        <tr
          class="flex flex-col md:table-row mb-4 md:mb-0 bg-white md:bg-transparent shadow md:shadow-none border border-purple-abbott md:border-none rounded-lg md:rounded-none overflow-hidden"
        >
          <td
            class="block md:table-cell p-4 md: text-black border border-purple-abbott text-center font-bold md:align-middle"
          >
            <span class="text-lg md:text-base">Synovular</span>
            <span
              class="block text-xs font-normal text-purple-abbott/80 md:text-gray-500 mt-1"
              >(DHPA 150 mg / E2EN 10 mg)</span
            >
          </td>
          <td
            class="block md:table-cell p-4 border border-purple-abbott  align-middle"
          >
            <span
              class="md:hidden text-black font-bold text-xs uppercase mb-2 block"
              >Beneficios:</span
            >
            <ul class="list-disc marker:text-[10px] text-xs md:text-sm">
              <li>Baja incidencia de eventos adversos con uso a largo plazo.<sup>5</sup></li>
              <li>Altas tasas de continuidad.<sup>5</sup></li>
            </ul>
          </td>
        </tr>

        <tr
          class="flex flex-col md:table-row mb-4 md:mb-0 bg-white md:bg-transparent shadow md:shadow-none border border-purple-abbott md:border-none rounded-lg md:rounded-none overflow-hidden"
        >
          <td
            class="block md:table-cell p-4 md:text-black border border-purple-abbott text-center font-bold md:align-middle"
          >
            <span class="text-lg md:text-base">Synovular suave</span>
            <span
              class="block text-xs font-normal text-purple-abbott/80 md:text-gray-500 mt-1"
              >(DHPA 90 mg / E2EN 6 mg)</span
            >
          </td>
          <td
            class="block md:table-cell p-4 border border-purple-abbott  align-middle"
          >
            <span
              class="md:hidden text-black font-bold text-xs uppercase mb-2 block"
              >Beneficios:</span
            >
            <ul class="list-disc marker:text-[10px] text-xs md:text-sm">
              <li>Seguridad y mayor tolerabilidad con menos carga hormonal.<sup>6</sup></li>
            </ul>
          </td>
        </tr>
      </tbody>
    </table>
  </div>

  <div class="mt-4 p-4 text-xs text-gray-600 space-y-1">
    <div class="">
      <p>*Tasa de embarazo en el primer año de uso.</p>
      <p><strong>DHPA:</strong> acetato de dihidroprogesterona; <strong>E2:</strong> estradiol; <strong>E2EN:</strong> enantato de estradiol; <strong>E2V:</strong> valerato de estradiol; <strong>EN-NET:</strong> enantato de noretisterona.</p>
    </div>
    <div class="mt-2">
      <strong>Referencias:</strong> <strong>1.</strong> Organización Mundial de la Salud (OMS). Planificación familiar. Un manual para proveedores [Internet]. OMS; 2019. Disponible en: https://bit.ly/2B50Pnw <strong>2.</strong> Gómez-Sánchez PI. Adherencia a anticoncepción hormonal combinada (inyectable y oral) en mujeres de 14 a 24 años de edad en 6 ciudades de Colombia. REVCOG 2017; 22:(4):77-83. <strong>3.</strong> Kaunitz AM. Lunelle monthly injectable contraceptive. An effective, safe, and convenient new birth control option. Arch Gynecol Obstet. 2001;265:119–123. <strong>4.</strong> Sierra-Ramírez JA, Lara-Ricalde R, Lujan M, Velázquez-Ramírez N, Godínez-Victoria M, Hernádez-Munguía I, et al. Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg). 4. Contraception. 2011 Dec;84(6):565-70. <strong>5.</strong> Jarquín González JD, Elda de Aguirre L, Rodríguez C, Abrego de Aguilar M, Carrillo F, León DA, et al. Dihydroxyprogesterone acetophenide 150 mg + estradiol enantate 10 mg as monthly injectable contraceptives. Adv Contracept. 1996 Sep;12(3):213-25. <strong>6.</strong> Coutinho EM, Spinola P, Tomaz G, Morais K, Nassar de Souza R, Sabino Pinho Neto J. Efficacy, acceptability, and clinical effects of a low-dose injectable contraceptive combination of dihydroxyprogesterone acetophenide and estradiol enanthate. Contraception. 2000 Apr;61(4):277-80.
    </div>
  </div>
</div>
